Biotechnological solution for large-scale production of mycelium, a natural key component in pharmaceutical, biomedical and agricultural industries
The mycelium natural product is a key component in many industrial applications of high economic value (pharmacological active principles, biomedical and biomaterials, agriculture or mycology and forest restoration). Obtaining one of their products (chitosan), with applications in agriculture and biomedical industry, is growing annually by 13%, an annual output of 2.000 tons and a global market estimated at 1,000 M $.
A research team from the EUIT Agricola at the Technical University of Madrid has developed a patented and internationally protected solution for mycelium production scale in a controlled manner and with a simplified process industrially from the multiplication of fungi in vitro culture. Mycetum business opportunity is checked as multi-application solution for a remarkable number of target markets, including the pharmaceutical one, world leader in R & D investment and technology. Mycetum, as a spin-off company, commercializes the solution.
This technological solution proposes an innovative method for obtaining global scale fungal mycelium in pure culture. The process develops inoculating the mycelium, for purification and then finally transfer for large-scale generation. This procedure can be implemented in industrial bioreactors for a rapid and controlled production.
The mycelium, a component of the fruit of the fungus, is a key component for the development of many applications of high economic value: extraction of active principles of pharmacological interest, obtaining chitosan (medicine, cosmetics, water treatment); obtaining principles food; biometariales generation and forest regeneration, among other applications.
“Patented technological process for obtaining a large-scale natural product from fungi (mycelium) for several high value industrial applications”
“Mycetum large-scale controlled production of mycelium improves key active ingredients generation for pharma industry”
Mycetum (UPM spin-off)
Consuelo Jiménez Aguilar, Francisco González Torres, Mª Cruz Usano Martínez, César González García
e: firstname.lastname@example.org; email@example.com
Innovation, Commercialization and Entrepreneurship Area
Centre of Support for Technological Innovation – UPM